Understanding Pharma Market Access & Payers in Europe

THE CONTENT
Market access is essential for brand success, yet achieving it in Europe’s complex and evolving healthcare systems is far from straightforward. Each country has its own structure, payer expectations, and decision-making processes. Navigating these effectively requires careful planning and cross-functional collaboration from Phase II onwards.

This course provides a clear and practical overview of how market access works across Europe’s major markets (EU4+UK). You will receive schematic reference overviews of each system, helping you understand how access decisions are made and what is required to optimise market access from early development onwards. Applying these insights will strengthen planning and collaboration between global and local teams, ensuring more aligned and effective access strategies.

To build the knowledge and confidence needed to navigate Europe’s diverse market access landscape, this course is a must-attend!

THE EXPERT
Dr Nick Proctor has been a trusted advisor on market access to the pharmaceutical industry for over 25 years, leading pricing, reimbursement, and market access projects for many of the world’s top pharmaceutical brands.

Megan O'Brien is an Associate Director at Access Infinity with over 10 years of pharmaceutical consultancy experience, specialising in pricing and market access, real-world evidence generation, and business intelligence.